Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 Placebo-Controlled, Double-Blind, Parallel-Group Study

Masataka Kuwana, Tomoki Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, Toshiya Kagoo, Kazuki Tanimoto, Natsuko Shichiri, So Saotome, Esteban Masuda, Yoshiaki Tomiyama

Blood (2023) 142 (Supplement 1): 2578.

https://doi.org/10.1182/blood-2023-182113

Published: 2023

Journal Articles

Fostamatinib for the Treatment of Japanese Patients with Primary Immune Thrombocytopenia: A Phase 3, Placebo-Controlled, Double-Blind, Parallel-Group Study

Blood (2022) 140 (Supplement 1): 11244–11245.

https://doi.org/10.1182/blood-2022-169782

Published: 2022

Journal Articles

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Miki Kobayashi, MD, Satoki Nakamura, MD, PhD, Kiyoshi Shibata, Naohi Sahara, MD, PhD, Kazuyuki Shigeno, MD, PhD, Kaori Shinjo, MD, PhD, Kensuke Naito, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2005) 106 (11): 4825.

https://doi.org/10.1182/blood.V106.11.4825.4825

Published: 2005

Journal Articles

Pharmacokinetics of Arsenic Species with Relapsed or Refractory Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO) in Japanese Patients.

Kazuyuki Shigeno, MD, Miki Kobayashi, MD, Naohi Sahara, MD, Satoki Nakamura, MD, Shinya Fujisawa, MD, Kensuke Naito, MD, Kaori Shinjo, MD, Akihiro Takeshita, MD, Ryuzo Ohno, MD, Kenji Kinoshita, PhD, Masahito Shimoya, PhD, Toshikazu Kaise, PhD, Kazunori Ohnishi, MD

Blood (2005) 106 (11): 4426.

https://doi.org/10.1182/blood.V106.11.4426.4426

Published: 2005

Journal Articles

Clinicopathological and Prognostic Characteristics of CD33-Positive Multiple Myeloma.

Naohi Sahara, Kazunori Ohnishi, Takaaki Ono, Yuya Sugimoto, Miki Kobaysahi, Kaori Takeshita, Kazuyuki Shigeno, Satoki Nakamura, Kensuke Naito, Akihiro Takeshita, Ryuzo Ohno

Blood (2005) 106 (11): 3409.

https://doi.org/10.1182/blood.V106.11.3409.3409

Published: 2005

Journal Articles

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Satoki Nakamura, MD, PhD, Miki Kobayashi, MD, Kiyoshi Shibata, Naohi Sahara, MD, Kazuyuki Shigeno, MD, PhD, Kaori Shinjo, MD, PhD, Kensuke Naito, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2004) 104 (11): 4836.

https://doi.org/10.1182/blood.V104.11.4836.4836

Published: 2004

Journal Articles

Role for Interleukin-6 and Insulin like Growth Factor-I Via PI3-K/Akt Pathway in the Proliferation of CD56-Negative and Positive Multiple Myeloma Cells.

Naohi Sahara, Akihiro Takeshita, Miki Kobayashi, Kazuyuki Shigeno, Satoki Nakamura, Kaori Shinjo, Kensuke Naito, Takemi Otsuki, Kazunori Ohnishi, Ryuzo Ohno

Blood (2004) 104 (11): 3365.

https://doi.org/10.1182/blood.V104.11.3365.3365

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 Placebo-Controlled, Double-Blind, Parallel-Group Study

Fostamatinib for the Treatment of Japanese Patients with Primary Immune Thrombocytopenia: A Phase 3, Placebo-Controlled, Double-Blind, Parallel-Group Study

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Pharmacokinetics of Arsenic Species with Relapsed or Refractory Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO) in Japanese Patients.

Clinicopathological and Prognostic Characteristics of CD33-Positive Multiple Myeloma.

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Role for Interleukin-6 and Insulin like Growth Factor-I Via PI3-K/Akt Pathway in the Proliferation of CD56-Negative and Positive Multiple Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

Update search

Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 Placebo-Controlled, Double-Blind, Parallel-Group Study

Fostamatinib for the Treatment of Japanese Patients with Primary Immune Thrombocytopenia: A Phase 3, Placebo-Controlled, Double-Blind, Parallel-Group Study

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Pharmacokinetics of Arsenic Species with Relapsed or Refractory Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO) in Japanese Patients.

Clinicopathological and Prognostic Characteristics of CD33-Positive Multiple Myeloma.

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Role for Interleukin-6 and Insulin like Growth Factor-I Via PI3-K/Akt Pathway in the Proliferation of CD56-Negative and Positive Multiple Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only